Review ArticleGiovanni Landoni, MDSection Editors?>Volatile Anesthetic-Induced Cardiac Protection: Molecular Mechanisms, Clinical Aspects, and Interactions With Nonvolatile Agents
Section snippets
Volatile Anesthetic-Induced Cardioprotection
A number of cardioprotective interventions using volatile anesthetics were identified since the original description of anesthetic-induced preconditioning (APC) in 1997.4 In this regard, actions during myocardial ischemia (state of low cellular pO2) and those happening during myocardial reperfusion (state of high cellular pO2) can be distinguished. Powerful protection via APC can be expected when administering volatile anesthetics before myocardial ischemia, with infarct size reductions of up
Cytosolic Signaling Pathways
Molecular pathways start at receptors of the cell membrane acting on inhibitory G-protein signaling,9 sarcolemmal ATP-dependent potassium channels (sarcKATP),10 β1- and β2-adrenergic receptors,11, 12, 13 and the adenosine-A1 receptor.14 Signal transmission is ensured through survival kinases, in particular phosphatidylinositol-3-kinase (PI3K) with subsequent Akt phosphorylation.15 Both interact with extracellular signal-regulated kinase 1 and 2 (Erk1/2) to form the reperfusion injury salvage
Mitochondrial Mechanisms
The mitochondrion represents a molecular center of cardioprotective signaling. All major mitochondrial functions are pivotal elements of cell survival. Most recently, a proteomics approach revealed that isoflurane-induced cardioprotection altered 98 mitochondrial proteins, emphasizing the importance of the mitochondrial respiratory chain as well as mitochondrial bioenergetics.33
Translocation of survival signaling to the organelle is accomplished mainly through the activation of different PKC
Clinical Studies
Although the use of volatile anesthetics has been identified as an important intervention that might reduce perioperative mortality,59 clinical data provide conflicting results. High concentrations of isoflurane and sevoflurane alleviate cardiac as well as renal damage after coronary artery bypass graft (CABG) surgery,60, 61 and a 1-year follow-up study by Zaugg et al62 suggested improved cardiovascular outcomes. DeHert et al63 corroborated these results while concomitantly challenging the need
Co-Factors Interacting with Volatile Anesthetic-Induced Cardioprotection
The biggest unresolved mystery limiting the clinical translation of any cardioprotective strategy relates to the interactions of age, co-medications, and co-diseases with the molecular pathways of survival signaling (Fig 3). The identification and restoration of the responsible molecular mechanisms represent an urgent goal to facilitate clinical translation. Multiple drugs and co-morbidities affecting volatile anesthetic-induced cardioprotection have been identified, including frequently used
Anesthetic Gases: Nitrous Oxide and Xenon
So far, nitrous oxide has proved to be the only negative exception among inhalation anesthetics with respect to its preconditioning abilities. Studies involving nitrous oxide failed to protect the rat heart in-vivo79 and demonstrated an increased mortality after I/R injury because of impaired recovery of stunned myocardium.80 However, the negative effect of this classic anesthetic is limited, because its mono-use is not feasible in clinical practice and concomitant use does not affect the
Beta-Adrenergic-Receptor Blockers
Beta-adrenergic-receptor blockers are well-known therapeutics in the treatment of coronary artery disease.96 Nevertheless, their beneficial effects often are scrutinized. Therapeutic efficacy in non-heart failure patients remains unclear and a recent observational study even suggested salutary effects might only exist after a prior history of myocardial infarction≤1 year. Patients with risk factors for CAD, those with known prior myocardial infarction>1 year, or CAD without myocardial
Alpha2-Adrenoceptor Agonists
Clonidine and dexmedetomidine long have been shown to protect the heart against ischemic damage, with clonidine’s hemodynamic effects benefiting myocardial oxygen supply and demand.99, 100 Perioperative clonidine administration over 4 days was found to be safe while reducing the risk of perioperative myocardial ischemia in patients undergoing elective noncardiac surgery. Furthermore, 30-day and 2-year survival significantly were improved.101 A meta-analysis including clonidine, mivazerol, and
Propofol
Alterations of the available molecular pathways not only concern long-term medication, but also intravenous anesthetics, most notably propofol. Propofol is a potential mitochondrion toxin, interfering with multiple mitochondrial signaling pathways including the respiratory chain. The propofol infusion syndrome, for example, mimics mitochondrial myopathies. It is caused by impaired entry of long-chain fatty acids, disruption of fatty-acid oxidation and failure of the respiratory chain at complex
Opioids
A number of opioids have been shown to protect the heart against I/R injury if administered before the ischemic insult or myocardial reperfusion. These include remifentanil,139 sufentanil,140 and fentanyl,141 as well as morphine.142, 143 The recruited molecular pathways feature kappa, mu, or delta opioid receptors,144, 145, 146 as well as common pathways of anesthetic or ischemic-induced cardioprotection. Increased Erk1/2 signaling, enhanced antiapoptotic mechanisms, inhibition of proapoptotic
Benzodiazepines
Benzodiazepines do not have cardioprotective effects, but still play an interesting and, to some extent, nebulous role within the paradigms of myocardial I/R damage. A prospective randomized study in pediatric patients did not show a significant difference in cardiac troponin postsurgery when comparing midazolam, propofol, or sevoflurane as the mainstay of anesthesia. However, troponin levels were nearly twice as high in patients receiving midazolam and propofol, suggesting a lack of power.152
Advanced Age
Aging is a dynamic process that alters the availability of numerous signaling pathways and increases the vulnerability to I/R injury. This includes a diminished responsiveness to volatile anesthetic-induced cardioprotection. Sevoflurane alleviated an intracellular pH decrease, Na+ and Ca2+ accumulation, as well as adenosine triphosphate recovery in young adult and middle-aged hearts. In the aged myocardium, these hallmarks of ischemic injury could not be improved.160 Similar results were found
Hyperglycemia and Diabetes Mellitus
Impaired glucose metabolism is one of the hallmarks of the metabolic syndrome and has a significant impact on the ability to condition the heart against I/R injury. Hyperglycemia with blood glucose concentrations of 300 or 600 mg/dL attenuates anesthetic-induced cardioprotection in a dose-dependent manner. Moderate hyperglycemia blocked the protective effects of 0.5 MAC of isoflurane and severe hyperglycemia prevented infarct size reductions while using up to 1.0 MAC.167 The same findings
Perspectives
Volatile anesthetic-induced cardioprotection is a fascinating and proliferative research area, providing a wealth of information on the molecular mechanisms targeted by volatile anesthetics. However, a number of major challenges remain. Clinical practice largely differs from the laboratory setting. The optimal treatment protocol is unknown and molecular interactions interfering with volatile anesthetic-induced cardioprotection are frequent. Advanced age or co-morbidities such as hyperglycemia
References (176)
- et al.
Time course of desflurane-induced preconditioning in rabbits
J Cardiothorac Vasc Anesth
(2010) - et al.
Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta 2-adrenergic receptors
J Cardiothorac Vasc Anesth
(2009) - et al.
Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling
Br J Anaesth
(2005) - et al.
Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A
Eur J Pharmacol
(2012) - et al.
Endothelial nitric oxide synthase mediates the first and inducible nitric oxide synthase mediates the second window of desflurane-induced preconditioning
J Cardiothorac Vasc Anesth
(2013) - et al.
Sevoflurane-induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species
Br J Anaesth
(2007) - et al.
K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms
J Mol Cell Cardiol
(2005) - et al.
Differential permeabilization effects of Ca2+and valinomycin on the inner and outer mitochondrial membranes as revealed by proteomics analysis of proteins released from mitochondria
Mol Cell Proteomics
(2009) - et al.
Randomized evidence for reduction of perioperative mortality
J Cardiothorac Vasc Anesth
(2012) - et al.
Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery
Br J Anaesth
(2005)
Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study
J Cardiothorac Vasc Anesth
Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study
J Cardiothorac Vasc Anesth
Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial
Br J Anaesth
The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures
J Cardiothorac Vasc Anesth
Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery
Br J Anaesth
Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1
Eur J Pharmacol
Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo
Br J Anaesth
The effect of xenon on isoflurane protection against experimental myocardial infarction
J Cardiothorac Vasc Anesth
Myocardial infarction after noncardiac surgery
Anesthesiology
Early and delayed myocardial infarction after abdominal aortic surgery
Anesthesiology
Reevaluation of perioperative myocardial infarction in patients with prior myocardial infarction undergoing noncardiac operations
Anesth Analg
Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase
Anesthesiology
Is isoflurane-induced preconditioning dose related?
Anesthesiology
Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo
Exp Biol Med (Maywood)
Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits
Anesthesiology
Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins
Anesthesiology
Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mechanism of desflurane-induced cardioprotection
Anesthesiology
Desflurane-induced postconditioning is mediated by beta-adrenergic signaling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II
Anesthesiology
Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: metoprolol blocks desflurane-induced preconditioning
Anesthesiology
Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels
Anesthesiology
Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo
Anesthesiology
Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo
Can J Anaesth
Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats
Anesth Analg
Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta
Anesthesiology
Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins
J Pharmacol Exp Ther
Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction
Anesthesiology
Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism
Anesthesiology
Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart
Am J Physiol Heart Circ Physiol
Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor-kappaB and upregulation of inducible nitric oxide synthase
Shock
Peroxisome-proliferator-activated receptor gamma mediates the second window of anaesthetic-induced preconditioning
Exp Physiol
Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway
Anesthesiology
Myocardial protection by isoflurane preconditioning preserves Ca2+cycling proteins independent of sarcolemmal and mitochondrial KATP channels
Anesth Analg
Protein kinase C-epsilon primes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to modulation by isoflurane
Anesthesiology
Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection
Anesthesiology
Quantitative characterization of changes in the cardiac mitochondrial proteome during anesthetic preconditioning and ischemia
Physiol Genomics
Desflurane-induced preconditioning alters calcium-induced mitochondrial permeability transition
Anesthesiology
Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection
J Clin Invest
Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade
Anesthesiology
Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species
Anesthesiology
Synergistic modulation of ATP-sensitive K+currents by protein kinase C and adenosine. Implications for ischemic preconditioning
Circ Res
Cited by (34)
Comparison of Volatile Anesthetics Versus Propofol on Postoperative Cognitive Function After Cardiac Surgery: A Systematic Review and Meta-analysis
2024, Journal of Cardiothoracic and Vascular AnesthesiaEffect of Volatile Anesthetics on Myocardial Infarction After Coronary Artery Surgery: A Post Hoc Analysis of a Randomized Trial
2022, Journal of Cardiothoracic and Vascular AnesthesiaVolatile and Intravenous Anesthetics for Brain Protection in Cardiac Surgery: Does the Choice of Anesthesia Matter?
2022, Journal of Cardiothoracic and Vascular AnesthesiaAnesthesia during cardiopulmonary bypass
2022, Cardiopulmonary Bypass: Advances in Extracorporeal Life SupportMolecular Cardioprotection and the Role of Exosomes: The Future Is Not Far Away
2021, Journal of Cardiothoracic and Vascular AnesthesiaCitation Excerpt :Early research on myocardial ischemic preconditioning offered the first mechanistic foundation for molecular cardioprotection. Ischemic preconditioning is a phenomenon in which transient cardiac ischemia triggers an adaptive response that makes the heart more resistant to injury from a larger subsequent ischemic episode.4-7 This was first demonstrated by Lowenstein et al. in 1976, who found that brief episodes of induced coronary artery occlusion and reperfusion before a prolonged ischemic event led to reduced ST- segment elevation.8